Stock A296160 PROGEN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Progen Co., Ltd.

Equities

A296160

KR7296160005

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-07-03 EDT 		5-day change 1st Jan Change
6,170 KRW +2.83% Intraday chart for Progen Co., Ltd. +4.05% -13.71%
06-24 Rani Therapeutics Holdings, Inc. Announces Partnership with ProGen Co., Ltd. on Development of Oral Obesity Treatment CI
01-31 Progen Co., Ltd. announced that it expects to receive KRW 9.71405799 billion in funding from Yuhan Corporation CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROGEN CO., LTD. Stock Progen Co., Ltd.
 50.07M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.44B -
LONZA GROUP AG Stock Lonza Group AG
 39.84B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.68B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.46B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.02B
  1. Stock Market
  2. Equities
  3. A296160 Stock
  4. Charts Progen Co., Ltd.
  5. Sector Chart